General Announcement::Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
14-Oct-2025 13:35:41
Status
New
Announcement Sub Title
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
Announcement Reference
SG251014OTHRIE11
Submitted By (Co./ Ind. Name)
Marbill De Gracia
Designation
Secretariat
Effective Date and Time of the event
14/10/2025 17:00:00
Description (Please provide a detailed description of the event in the box below)
TELIX PHARMACEUTICALS LIMITED Periodic Report announced on ASX

Attachments

20251014 Telix Q3 2025 Business Update vFINAL.pdf
Total size =142K